BioSig Technologies, Inc. (BSGM)
USD 1.28
(-3.76%)
USD 1.28
(-3.76%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 4.68 Million USD | 26.18% |
| 2022 | 3.71 Million USD | 25.69% |
| 2021 | 2.95 Million USD | -42.18% |
| 2020 | 5.1 Million USD | 118.27% |
| 2019 | 2.34 Million USD | 95.45% |
| 2018 | 1.19 Million USD | -69.8% |
| 2017 | 3.96 Million USD | 34.0% |
| 2016 | 2.95 Million USD | 19.79% |
| 2015 | 2.47 Million USD | 101.58% |
| 2014 | 1.22 Million USD | -59.39% |
| 2013 | 3.01 Million USD | 91.1% |
| 2012 | 1.57 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 5.79 Million USD | 23.63% |
| 2024 Q2 | 2.99 Million USD | -48.36% |
| 2023 Q3 | 4.1 Million USD | 13.56% |
| 2023 Q4 | 4.68 Million USD | 14.16% |
| 2023 FY | 4.68 Million USD | 26.18% |
| 2023 Q1 | 3.18 Million USD | -14.3% |
| 2023 Q2 | 3.61 Million USD | 13.58% |
| 2022 Q3 | 3.07 Million USD | 22.65% |
| 2022 Q4 | 3.71 Million USD | 20.71% |
| 2022 Q1 | 3.02 Million USD | 2.47% |
| 2022 FY | 3.71 Million USD | 25.69% |
| 2022 Q2 | 2.5 Million USD | -17.15% |
| 2021 FY | 2.95 Million USD | -42.18% |
| 2021 Q3 | 2.99 Million USD | -12.1% |
| 2021 Q4 | 2.95 Million USD | -1.3% |
| 2021 Q1 | 3.95 Million USD | -22.63% |
| 2021 Q2 | 3.4 Million USD | -13.86% |
| 2020 FY | 5.1 Million USD | 118.27% |
| 2020 Q1 | 1.78 Million USD | -23.72% |
| 2020 Q2 | 3.69 Million USD | 106.96% |
| 2020 Q3 | 4.98 Million USD | 34.83% |
| 2020 Q4 | 5.1 Million USD | 2.55% |
| 2019 Q2 | 1.88 Million USD | 52.32% |
| 2019 FY | 2.34 Million USD | 95.45% |
| 2019 Q1 | 1.23 Million USD | 3.19% |
| 2019 Q3 | 1.58 Million USD | -15.61% |
| 2019 Q4 | 2.34 Million USD | 47.34% |
| 2018 Q3 | 720.36 Thousand USD | 37.15% |
| 2018 FY | 1.19 Million USD | -69.8% |
| 2018 Q4 | 1.19 Million USD | 66.24% |
| 2018 Q2 | 525.23 Thousand USD | -36.06% |
| 2018 Q1 | 821.44 Thousand USD | -79.28% |
| 2017 Q1 | 3.56 Million USD | 20.49% |
| 2017 Q2 | 4.26 Million USD | 19.73% |
| 2017 Q3 | 4.22 Million USD | -1.05% |
| 2017 Q4 | 3.96 Million USD | -6.13% |
| 2017 FY | 3.96 Million USD | 34.0% |
| 2016 Q1 | 2.75 Million USD | 11.66% |
| 2016 FY | 2.95 Million USD | 19.79% |
| 2016 Q3 | 3.38 Million USD | 5.04% |
| 2016 Q4 | 2.95 Million USD | -12.54% |
| 2016 Q2 | 3.22 Million USD | 16.78% |
| 2015 Q1 | 6.76 Million USD | 451.98% |
| 2015 Q4 | 2.47 Million USD | -9.1% |
| 2015 Q3 | 2.71 Million USD | -52.26% |
| 2015 Q2 | 5.69 Million USD | -15.84% |
| 2015 FY | 2.47 Million USD | 101.58% |
| 2014 Q2 | 883.44 Thousand USD | -21.15% |
| 2014 Q3 | 837.13 Thousand USD | -5.24% |
| 2014 Q4 | 1.22 Million USD | 46.38% |
| 2014 Q1 | 1.12 Million USD | -62.87% |
| 2014 FY | 1.22 Million USD | -59.39% |
| 2013 Q3 | 865.14 Thousand USD | -65.22% |
| 2013 Q1 | 693.37 Thousand USD | -56.09% |
| 2013 Q2 | 2.48 Million USD | 258.77% |
| 2013 FY | 3.01 Million USD | 91.1% |
| 2013 Q4 | 3.01 Million USD | 248.79% |
| 2012 Q4 | 1.57 Million USD | 0.0% |
| 2012 FY | 1.57 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acutus Medical, Inc. | 54.83 Million USD | 91.457% |
| Axonics, Inc. | 82.35 Million USD | 94.311% |
| INVO Bioscience, Inc. | 19.99 Million USD | 76.569% |
| CVRx, Inc. | 39.28 Million USD | 88.073% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 97.9% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -47.237% |
| MaxCyte, Inc. | 36.1 Million USD | 87.025% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 78.197% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 96.221% |
| Sintx Technologies, Inc. | 6.59 Million USD | 28.94% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 90.859% |
| Apyx Medical Corporation | 52.31 Million USD | 91.045% |
| Cutera, Inc. | 518.12 Million USD | 99.096% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | 12.299% |
| NeuroPace, Inc. | 86.99 Million USD | 94.615% |
| IRIDEX Corporation | 24.91 Million USD | 81.195% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 94.664% |
| enVVeno Medical Corporation | 2.43 Million USD | -92.402% |
| TELA Bio, Inc. | 59.16 Million USD | 92.082% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.267% |
| UFP Technologies, Inc. | 118.04 Million USD | 96.031% |
| Modular Medical, Inc. | 2.27 Million USD | -106.206% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 84.026% |
| LENSAR, Inc. | 22.4 Million USD | 79.093% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.786% |
| Surmodics, Inc. | 65.82 Million USD | 92.882% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 54.598% |
| Inogen, Inc. | 121.38 Million USD | 96.14% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -179.869% |
| RxSight, Inc. | 22.18 Million USD | 78.885% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -1001.625% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 84.162% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 79.748% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -1001.625% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -92.854% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 95.521% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.334% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 81.601% |
| Dynatronics Corporation | 11.78 Million USD | 60.23% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 90.932% |
| InMode Ltd. | 75.91 Million USD | 93.829% |
| Bruker Corporation | 2.83 Billion USD | 99.835% |
| Movano Inc. | 5.97 Million USD | 21.551% |
| Orthofix Medical Inc. | 326.58 Million USD | 98.565% |
| FONAR Corporation | 57.45 Million USD | 91.846% |
| Envoy Medical, Inc. | 9.4 Million USD | 50.17% |
| Align Technology, Inc. | 2.45 Billion USD | 99.809% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 91.973% |
| Talis Biomedical Corporation | 29.22 Million USD | 83.969% |
| Cerus Corporation | 144.3 Million USD | 96.753% |
| 908 Devices Inc. | 37.49 Million USD | 87.503% |
| Nemaura Medical Inc. | 26.37 Million USD | 82.239% |
| Outset Medical, Inc. | 190.91 Million USD | 97.546% |
| NanoVibronix, Inc. | 2.68 Million USD | -74.423% |
| Venus Concept Inc. | 107.1 Million USD | 95.626% |
| Telesis Bio, Inc. | 40.87 Million USD | 88.538% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 95.889% |
| Quipt Home Medical Corp. | 136.29 Million USD | 96.563% |
| IRadimed Corporation | 20.73 Million USD | 77.406% |
| Tenon Medical, Inc. | 5.56 Million USD | 15.843% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -31.159% |
| Pulmonx Corporation | 60.63 Million USD | 92.274% |
| iCAD, Inc. | 8 Million USD | 41.445% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 63.083% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -153.53% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 88.514% |
| SI-BONE, Inc. | 61.05 Million USD | 92.326% |
| Semler Scientific, Inc. | 6.27 Million USD | 25.279% |
| Biotricity, Inc. | 35.91 Million USD | 86.957% |
| Cytosorbents Corporation | 29.98 Million USD | 84.376% |
| DexCom, Inc. | 4.19 Billion USD | 99.888% |
| ZimVie Inc. | 795.85 Million USD | 99.411% |
| Aethlon Medical, Inc. | 2.47 Million USD | -88.938% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 60.821% |
| IceCure Medical Ltd | 4.24 Million USD | -10.313% |
| PAVmed Inc | 57.13 Million USD | 91.8% |
| Sight Sciences, Inc. | 46.43 Million USD | 89.911% |
| Insulet Corporation | 1.85 Billion USD | 99.748% |
| Profound Medical Corp. | 12.66 Million USD | 63.011% |
| electroCore, Inc. | 8.94 Million USD | 47.624% |
| Bioventus Inc. | 589.79 Million USD | 99.206% |
| InspireMD, Inc. | 8.14 Million USD | 42.459% |
| PAVmed Inc. | 57.13 Million USD | 91.8% |
| Nuwellis, Inc. | 6.78 Million USD | 30.9% |
| OrthoPediatrics Corp. | 72.56 Million USD | 93.543% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 60.821% |
| BrainsWay Ltd. | 15.31 Million USD | 69.407% |
| BIOLASE, Inc. | 35.34 Million USD | 86.746% |
| Beyond Air, Inc. | 29.77 Million USD | 84.265% |
| AxoGen, Inc. | 101.16 Million USD | 95.369% |
| Inari Medical, Inc. | 209.32 Million USD | 97.762% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -114.337% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -163.35% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.851% |
| Quanterix Corporation | 78.08 Million USD | 94.0% |
| Viveve Medical, Inc. | 10.84 Million USD | 56.808% |
| LivaNova PLC | 1.15 Billion USD | 99.593% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 73.432% |
| Varex Imaging Corporation | 668.6 Million USD | 99.299% |
| Vivani Medical, Inc. | 25.03 Million USD | 81.287% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -15.281% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -31.159% |
| Sensus Healthcare, Inc. | 4.88 Million USD | 4.094% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.552% |
| TransMedics Group, Inc. | 568.84 Million USD | 99.176% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 71.916% |
| NeuroMetrix, Inc. | 1.33 Million USD | -251.43% |
| Spectral AI, Inc. | 12.4 Million USD | 62.221% |
| Hyperfine, Inc. | 9.8 Million USD | 52.194% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 98.128% |
| Biomerica, Inc. | 2.66 Million USD | -75.929% |
| Bone Biologics Corporation | 831.4 Thousand USD | -463.506% |
| AVITA Medical, Inc. | 19.86 Million USD | 76.416% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -137.373% |
| Silk Road Medical, Inc | 114.15 Million USD | 95.896% |